Data from the SCID mouse chimera provided circumstantial evidence that IL-18 may be an effective monocyte recruitment factor in chronic diseases and supported previous findings that IL-18 gene-knockout mice have reduced inflammation in relevant models of RA [1]. Here, IL18 is linked to rheumatoid arthritis.